CClinicalTrials.gg
CompletedNCT05276986Updated Mar 14, 2022

Effects of Delayed Muscle Pain on Respiratory Muscle Function

An interventional study of DOMS protocol in Muscle Soreness, Exercise and Respiratory Muscles, sponsored by Ankara Yildirim Beyazıt University. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-14.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Screening

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Nov 2019, registered Jan 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years to 24 Years
Sex
All
01

Study summary

The aim of the study was to determine whether delayed-onset muscle soreness (DOMS) in trunk muscles has an effect on respiratory function parameters, respiratory muscle strength, respiratory muscle endurance, and exercise capacity.

Read the detailed description

In 24 healthy university students was induced for the trunk muscles with a load equals to 80% of the maximum repetitive voluntary contraction. Pulmonary function parameters, respiratory muscle strength and endurance, exercise capacity, pain, fatigue, and dyspnea perception severity were recorded before DOMS and at the 24th and 48th hours after DOMS.

After DOMS, there is a decrease in respiratory performance values and exercise capacity of healthy individuals and athletes. Therefore, it should be taken into account that delayed muscle soreness before the competition may affect performance. It may be beneficial to take precautions for delayed muscle pain while creating training and exercise programs, and to create treatment programs in case of the emergence of DOMS.

02

Conditions studied

  • Muscle Soreness
  • Exercise
  • Respiratory Muscles
  • Respiratory Function Tests

Browse trials for

Keywords

  • Muscle Soreness
  • Exercise
  • Respiratory Muscles
  • Respiratory Function Tests
03

In context

Myalgia

282 studies on the registry are indexed under Myalgia; 43 are open to participants now.

This study's enrollment of 24 is below the median of 44 across 241 interventional studies indexed under Myalgia.

Browse Myalgia studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 228 studies on the registry; 53 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being a healthy individual between the ages of 18-25
  • Not having a regular exercise habit
  • No infection until at least 3 weeks before the study

Exclusion criteria

Exclusion Criteria:

  • Lung disease
  • Cardiovascular disease
  • Neurological disease
  • Orthopedic disease
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    DOMS protocol group

    DOMS was induced for the trunk muscles with a load equals to 80% of the maximum repetitive voluntary contraction. Pulmonary function parameters, respiratory muscle strength and endurance, exercise capacity, pain, fatigue, and dyspnea perception severity were recorded before DOMS and at the 24th and 48th hours after DOMS.

    Other: DOMS protocol

Interventions

  • OtherDOMS protocol

    For a maximum repetition of the trunk muscles, two measurements were made with a 45-second rest interval.The values were recorded in Newtons by taking the maximum value of the two repetitions measured. DOMS was formed by eccentric contraction with 80% of this determined value.To generate DOMS in the trunk, participants were seated on the bench with the knees flexed at 90° and the soles of the feet in full contact with the floor, keeping the weight at 80% of the predetermined maximum repetition.The participants were asked to perform trunk extension with eccentric contraction of the trunk in 5 seconds, and trunk flexion with concentric contraction in 3 seconds.Two-minute rests between sets and 45-second rests between repetitions were given.The date and time of the created DOMS were recorded and the measurements were repeated at the 24th and 48th hours.

06

What researchers measure

Primary outcomes

  1. Pulmonary Function Tests (FVC)

    Forced vital capacity (FVC) was evaluated. The volume of air that is exhaled quickly and strongly following a deep inspiration. Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used.

    Time frame: Pulmonary function test measurements were made in all individuals at baseline.

  2. Pulmonary Function Tests (FEV1)

    Forced expiratory volume in the first second (FEV1) was evaluated. It is the volume of air expelled in the first second from the start of the forced vital capacity maneuver. It gives information about the restriction on major airlines in general.Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used. Individuals were asked to make a forced expiration after maximum inspiration.

    Time frame: Pulmonary function test measurements were made in all individuals at baseline.

  3. Pulmonary Function Tests (FEF25%-75%)

    Flow rate value of forced expiratory volume (FEF25%-75%) was evaluated. It is the mean flow rate in 50% of the forced vital capacity maneuver. Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used. Individuals were asked to make a forced expiration after maximum inspiration.

    Time frame: Pulmonary function test measurements were made in all individuals at baseline.

  4. Pulmonary Function Tests (VC)

    Vital capacity (VC) was evaluated. It is the volume of air in the lungs that varies between full inspiration and maximum expiration. It is possible to measure the volume of both a slow and vigorous exhalation after a deep inspiration.Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used.

    Time frame: Pulmonary function test measurements were made in all individuals at baseline.

  5. Pulmonary Function Tests (FVC)

    Forced vital capacity (FVC) was evaluated. The volume of air that is exhaled quickly and strongly following a deep inspiration. Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used.

    Time frame: Pulmonary function test measurements were made in all individuals at the 24th hours after the trunk-oriented DOMS.

  6. Pulmonary Function Tests (FEV1)

    Forced expiratory volume in the first second (FEV1) was evaluated. It is the volume of air expelled in the first second from the start of the forced vital capacity maneuver. It gives information about the restriction on major airlines in general.Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used. Individuals were asked to make a forced expiration after maximum inspiration.

    Time frame: Pulmonary function test measurements were made in all individuals at the 24th hours after the trunk-oriented DOMS.

  7. Pulmonary Function Tests (FEF25%-75%)

    Flow rate value of forced expiratory volume (FEF25%-75%) was evaluated. It is the mean flow rate in 50% of the forced vital capacity maneuver. Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used. Individuals were asked to make a forced expiration after maximum inspiration.

    Time frame: Pulmonary function test measurements were made in all individuals at the 24th hours after the trunk-oriented DOMS.

  8. Pulmonary Function Tests (VC)

    Vital capacity (VC) was evaluated. It is the volume of air in the lungs that varies between full inspiration and maximum expiration. It is possible to measure the volume of both a slow and vigorous exhalation after a deep inspiration.Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used.

    Time frame: Pulmonary function test measurements were made in all individuals at the 24th hours after the trunk-oriented DOMS.

  9. Pulmonary Function Tests (FVC)

    Forced vital capacity (FVC) was evaluated. The volume of air that is exhaled quickly and strongly following a deep inspiration. Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used.

    Time frame: Pulmonary function test measurements were made in all individuals at the 48th hours after the trunk-oriented DOMS.

  10. Pulmonary Function Tests (FEV1)

    Forced expiratory volume in the first second (FEV1) was evaluated. It is the volume of air expelled in the first second from the start of the forced vital capacity maneuver. It gives information about the restriction on major airlines in general.Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used. Individuals were asked to make a forced expiration after maximum inspiration.

    Time frame: Pulmonary function test measurements were made in all individuals at the 48th hours after the trunk-oriented DOMS.

  11. Pulmonary Function Tests (FEF25%-75%)

    Flow rate value of forced expiratory volume (FEF25%-75%) was evaluated. It is the mean flow rate in 50% of the forced vital capacity maneuver. Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used. Individuals were asked to make a forced expiration after maximum inspiration.

    Time frame: Pulmonary function test measurements were made in all individuals at the 48th hours after the trunk-oriented DOMS.

  12. Pulmonary Function Tests (VC)

    Vital capacity (VC) was evaluated. It is the volume of air in the lungs that varies between full inspiration and maximum expiration. It is possible to measure the volume of both a slow and vigorous exhalation after a deep inspiration.Test were performed using a portable spirometer (MIR Spirolab III srl, Italy). During the test, the subject was in a sitting position and their nose was clamped. The test were repeated three times and the best measurement value was used.

    Time frame: Pulmonary function test measurements were made in all individuals at the 48th hours after the trunk-oriented DOMS.

  13. Respiratory Muscle Strength Measurement

    Respiratory muscle strength validity and reliability were demonstrated by measuring maximal inspiratory (MIP) and maximal expiratory (MEP) pressures with a portable intraoral pressure measuring device (MicroRPM Respiratory Muscle Testing, Germany). Measurements were made using a clamp that prevents nasal breathing and were performed 5 times until a difference of 5 cmH2O remained, with a 30-second rest period between measurements to record the best value, and the best result was recorded in cmH2O. The recorded values were calculated and recorded with the expected values according to age and gender.

    Time frame: This test was carried out at baseline.

  14. Respiratory Muscle Strength Measurement

    Respiratory muscle strength validity and reliability were demonstrated by measuring maximal inspiratory (MIP) and maximal expiratory (MEP) pressures with a portable intraoral pressure measuring device (MicroRPM Respiratory Muscle Testing, Germany). Measurements were made using a clamp that prevents nasal breathing and were performed 5 times until a difference of 5 cmH2O remained, with a 30-second rest period between measurements to record the best value, and the best result was recorded in cmH2O. The recorded values were calculated and recorded with the expected values according to age and gender.

    Time frame: This test was carried out at the 24th after DOMS.

  15. Respiratory Muscle Strength Measurement

    Respiratory muscle strength validity and reliability were demonstrated by measuring maximal inspiratory (MIP) and maximal expiratory (MEP) pressures with a portable intraoral pressure measuring device (MicroRPM Respiratory Muscle Testing, Germany). Measurements were made using a clamp that prevents nasal breathing and were performed 5 times until a difference of 5 cmH2O remained, with a 30-second rest period between measurements to record the best value, and the best result was recorded in cmH2O. The recorded values were calculated and recorded with the expected values according to age and gender.

    Time frame: This test was carried out at 48th hours after DOMS.

  16. Respiratory Muscle Endurance Test

    Respiratory muscle endurance was evaluated with a threshold-loaded (constant) respiratory muscle trainer (Power Breathe®, POWERbreathe International Ltd. Warwickshire, England) with proven validity and reliability . In the evaluation, measurements were made in the upright sitting position in the chair while the nose of the individuals was closed with a clip. Initial workload was applied at 60% of the maximal inspiratory pressure. Participants were asked to continue inspiring despite constant inspiratory workload. The respiratory muscle endurance value was obtained by multiplying the maximum workload of the test that can be sustained for at least one minute. Individuals were told that the test could be terminated if severe fatigue and extreme shortness of breath were experienced during the test. The results of the test were recorded.

    Time frame: This test was performed at baseline.

  17. Respiratory Muscle Endurance Test

    Respiratory muscle endurance was evaluated with a threshold-loaded (constant) respiratory muscle trainer (Power Breathe®, POWERbreathe International Ltd. Warwickshire, England) with proven validity and reliability . In the evaluation, measurements were made in the upright sitting position in the chair while the nose of the individuals was closed with a clip. Initial workload was applied at 60% of the maximal inspiratory pressure. Participants were asked to continue inspiring despite constant inspiratory workload. The respiratory muscle endurance value was obtained by multiplying the maximum workload of the test that can be sustained for at least one minute. Individuals were told that the test could be terminated if severe fatigue and extreme shortness of breath were experienced during the test. The results of the test were recorded.

    Time frame: This test was performed at 24 hours after DOMS.

  18. Respiratory Muscle Endurance Test

    Respiratory muscle endurance was evaluated with a threshold-loaded (constant) respiratory muscle trainer (Power Breathe®, POWERbreathe International Ltd. Warwickshire, England) with proven validity and reliability . In the evaluation, measurements were made in the upright sitting position in the chair while the nose of the individuals was closed with a clip. Initial workload was applied at 60% of the maximal inspiratory pressure. Participants were asked to continue inspiring despite constant inspiratory workload. The respiratory muscle endurance value was obtained by multiplying the maximum workload of the test that can be sustained for at least one minute. Individuals were told that the test could be terminated if severe fatigue and extreme shortness of breath were experienced during the test. The results of the test were recorded.

    Time frame: This test was performed at 48 hours after DOMS.

  19. Exercise Capacity

    The exercise capacity of the individuals was evaluated with the 6-Minute Walk Test (6 MWT), a submaximal test with high validity and reliability (ICC=0.94). 6MWT, made according to the American Thoracic Society guidlines.The distance covered in a 6-minute walk was calculated from the number of laps and meters. Values were recorded as a percentage of expected values for age and sex.

    Time frame: This test was carried out at baseline.

  20. Exercise Capacity

    The exercise capacity of the individuals was evaluated with the 6-Minute Walk Test (6 MWT), a submaximal test with high validity and reliability (ICC=0.94). 6MWT, made according to the American Thoracic Society guidlines.The distance covered in a 6-minute walk was calculated from the number of laps and meters. Values were recorded as a percentage of expected values for age and sex.

    Time frame: This test was carried out at the 24th hours after DOMS.

  21. Exercise Capacity

    The exercise capacity of the individuals was evaluated with the 6-Minute Walk Test (6 MWT), a submaximal test with high validity and reliability (ICC=0.94). 6MWT, made according to the American Thoracic Society guidlines.The distance covered in a 6-minute walk was calculated from the number of laps and meters. Values were recorded as a percentage of expected values for age and sex.

    Time frame: This test was carried out at 48th hours after DOMS.

07

Study locations

2 sites
  • Ankara Yildirim Beyazit University,Faculty of Health Sciences, Physiotherapy and Rehabilitation Department
    Ankara, Turkey
  • Faculty of Health Sciences, Departmant of Physiotherapy and Rehabilitation, Baskent University
    Ankara, Turkey
08

References and documents

Publications

  • Benditt JO. Respiratory Care of Patients With Neuromuscular Disease. Respir Care. 2019 Jun;64(6):679-688. doi: 10.4187/respcare.06827. PubMed 31110036 ↗
  • Lieber RL, Friden J. Morphologic and mechanical basis of delayed-onset muscle soreness. J Am Acad Orthop Surg. 2002 Jan-Feb;10(1):67-73. PubMed 11809052 ↗
  • Imtiyaz S, Veqar Z, Shareef MY. To Compare the Effect of Vibration Therapy and Massage in Prevention of Delayed Onset Muscle Soreness (DOMS). J Clin Diagn Res. 2014 Jan;8(1):133-6. doi: 10.7860/JCDR/2014/7294.3971. Epub 2014 Jan 12. PubMed 24596744 ↗
  • Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness : treatment strategies and performance factors. Sports Med. 2003;33(2):145-64. doi: 10.2165/00007256-200333020-00005. PubMed 12617692 ↗
  • Jamurtas AZ, Theocharis V, Tofas T, Tsiokanos A, Yfanti C, Paschalis V, Koutedakis Y, Nosaka K. Comparison between leg and arm eccentric exercises of the same relative intensity on indices of muscle damage. Eur J Appl Physiol. 2005 Oct;95(2-3):179-85. doi: 10.1007/s00421-005-1345-0. Epub 2005 Jul 9. PubMed 16007451 ↗
  • Hotta N, Yamamoto K, Katayama K, Ishida K. The respiratory response to passive and active arm movements is enhanced in delayed onset muscle soreness. Eur J Appl Physiol. 2009 Feb;105(3):483-91. doi: 10.1007/s00421-008-0926-0. Epub 2008 Nov 15. PubMed 19015869 ↗
  • Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969 May;99(5):696-702. doi: 10.1164/arrd.1969.99.5.696. No abstract available. PubMed 5772056 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05276986
Lead sponsor
Ankara Yildirim Beyazıt University
Responsible party
Sponsor
First posted
Mar 14, 2022
Start date
Nov 17, 2019
Primary completion
Jan 12, 2020
Completion
Jan 12, 2020
Last update
Mar 14, 2022

Study contacts

Sema Ozden
principal investigator · Cyprus International University, School of Physical Education and Sports
Ozge Ozalp
study director · Cyprus International University, Faculty of Health Sciences,Department of Physiotherapy and Rehabilitation
Rabia Tugba Kilic
study director · Ankara Yildirim Beyazit University,Faculty of Health Sciences, Physiotherapy and Rehabilitation Department
Hayri Baran Yosmaoglu
study chair · Baskent University, Physiotherapy and Rehabilitation Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion